Home/Filings/4/0001213900-19-021428
4//SEC Filing

WINDSOR JAMES BRIAN 4

Accession 0001213900-19-021428

CIK 0001733413other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 8:35 PM ET

Size

6.9 KB

Accession

0001213900-19-021428

Insider Transaction Report

Form 4
Period: 2019-10-25
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2019-10-29+43,794135,806 total
    Exercise: $5.00Exp: 2029-10-29Common Stock (43,794 underlying)
  • Purchase

    Common Stock

    2019-10-25$5.00/sh+5,000$25,0005,000 total
Footnotes (2)
  • [F1]The shares of common stock purchased in the Issuer's initial public offering.
  • [F2]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.

Documents

1 file

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother

Related Parties

1
  • filerCIK 0001790933

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:35 PM ET
Size
6.9 KB